VERTEX PHARMACEUTICALS INC / MA Annual Current Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Vertex Pharmaceuticals Inc / Ma annual Current Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Vertex Pharmaceuticals Inc / Ma annual Current Income Tax Expense (Benefit) for 2023 was $1.3B, a 9.31% increase from 2022.
  • Vertex Pharmaceuticals Inc / Ma annual Current Income Tax Expense (Benefit) for 2022 was $1.19B, a 119% increase from 2021.
  • Vertex Pharmaceuticals Inc / Ma annual Current Income Tax Expense (Benefit) for 2021 was $543M, a 324% increase from 2020.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.3B +$110M +9.31% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $1.19B +$643M +119% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $543M +$415M +324% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $128M +$77.2M +152% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 $50.7M +$25.3M +99.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 $25.4M +$5.23M +25.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $20.2M +$20.4M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 -$191K -$30.3M -101% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-13
2015 $30.1M +$23.4M +351% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $6.68M +$1.51M +29.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $5.17M +$5.44M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-16
2012 -$275K -$30.6M -101% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 $30.4M +$30.4M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
2010 $0 Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.